164 related articles for article (PubMed ID: 17307212)
1. Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3).
Pahar B; Wang X; Dufour J; Lackner AA; Veazey RS
Virology; 2007 Jun; 363(1):36-47. PubMed ID: 17307212
[TBL] [Abstract][Full Text] [Related]
2. SHIV-C109p5 NHP induces rapid disease progression in elderly macaques with extensive GI viral replication.
Bose D; Deb Adhikary N; Xiao P; Rogers KA; Ferrell DE; Cheng-Mayer C; Chang TL; Villinger F
J Virol; 2024 Feb; 98(2):e0165223. PubMed ID: 38299866
[TBL] [Abstract][Full Text] [Related]
3. SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.
Dashti A; Waller C; Mavigner M; Schoof N; Bar KJ; Shaw GM; Vanderford TH; Liang S; Lifson JD; Dunham RM; Ferrari G; Tuyishime M; Lam CK; Nordstrom JL; Margolis DM; Silvestri G; Chahroudi A
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817214
[TBL] [Abstract][Full Text] [Related]
4. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
5. Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virus.
von Gegerfelt A; Valentin A; Alicea C; Van Rompay KK; Marthas ML; Montefiori DC; Pavlakis GN; Felber BK
J Immunol; 2010 Sep; 185(6):3348-58. PubMed ID: 20702730
[TBL] [Abstract][Full Text] [Related]
6. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ
J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741
[TBL] [Abstract][Full Text] [Related]
7. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
[TBL] [Abstract][Full Text] [Related]
8. Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.
Breed MW; Elser SE; Torben W; Jordan AP; Aye PP; Midkiff C; Schiro F; Sugimoto C; Alvarez-Hernandez X; Blair RV; Somasunderam A; Utay NS; Kuroda MJ; Pahar B; Wiseman RW; O'Connor DH; LaBranche CC; Montefiori DC; Marsh M; Li Y; Piatak M; Lifson JD; Keele BF; Fultz PN; Lackner AA; Hoxie JA
J Virol; 2015 Oct; 89(20):10156-75. PubMed ID: 26223646
[TBL] [Abstract][Full Text] [Related]
9. Early Env-specific CTLs effectively suppress viral replication in SHIV controller macaques.
Fan J; Liang H; Shen T; Wang S; Ji X; Yee C; Lu F; Shao Y
Cell Immunol; 2018 Sep; 331():30-37. PubMed ID: 29773224
[TBL] [Abstract][Full Text] [Related]
10. Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.
Mooij P; Nieuwenhuis IG; Knoop CJ; Doms RW; Bogers WM; Ten Haaft PJ; Niphuis H; Koornstra W; Bieler K; Köstler J; Morein B; Cafaro A; Ensoli B; Wagner R; Heeney JL
J Virol; 2004 Apr; 78(7):3333-42. PubMed ID: 15016855
[TBL] [Abstract][Full Text] [Related]
11. SHIV antigen immunization alters patterns of immune responses to SHIV/malaria coinfection and protects against life-threatening SHIV-related malaria.
Frencher JT; Ryan-Pasyeur BK; Huang D; Wang RC; McMullen PD; Letvin NL; Collins WE; Freitag NE; Malkovsky M; Chen CY; Shen L; Chen ZW
J Infect Dis; 2013 Jul; 208(2):260-70. PubMed ID: 23568175
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication.
Pallikkuth S; Rogers K; Villinger F; Dosterii M; Vaccari M; Franchini G; Pahwa R; Pahwa S
Vaccine; 2011 Nov; 29(49):9229-38. PubMed ID: 21996099
[TBL] [Abstract][Full Text] [Related]
13. Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection.
Kenway-Lynch CS; Das A; Lackner AA; Pahar B
J Virol; 2014 Aug; 88(16):9442-57. PubMed ID: 24920807
[TBL] [Abstract][Full Text] [Related]
14. Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.
Ziani W; Bauer A; Lu H; Wang X; Wu X; Bar KJ; Li H; Liu D; Shaw GM; Veazey RS; Xu H
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568508
[TBL] [Abstract][Full Text] [Related]
15. Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.
Tasca S; Tsai L; Trunova N; Gettie A; Saifuddin M; Bohm R; Chakrabarti L; Cheng-Mayer C
Virology; 2007 Oct; 367(1):196-211. PubMed ID: 17574643
[TBL] [Abstract][Full Text] [Related]
16. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.
Mueller YM; Do DH; Altork SR; Artlett CM; Gracely EJ; Katsetos CD; Legido A; Villinger F; Altman JD; Brown CR; Lewis MG; Katsikis PD
J Immunol; 2008 Jan; 180(1):350-60. PubMed ID: 18097036
[TBL] [Abstract][Full Text] [Related]
17. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
[TBL] [Abstract][Full Text] [Related]
18. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
Loffredo JT; Bean AT; Beal DR; León EJ; May GE; Piaskowski SM; Furlott JR; Reed J; Musani SK; Rakasz EG; Friedrich TC; Wilson NA; Allison DB; Watkins DI
J Virol; 2008 Feb; 82(4):1723-38. PubMed ID: 18057253
[TBL] [Abstract][Full Text] [Related]
19. Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.
Kaur A; Grant RM; Means RE; McClure H; Feinberg M; Johnson RP
J Virol; 1998 Dec; 72(12):9597-611. PubMed ID: 9811693
[TBL] [Abstract][Full Text] [Related]
20. Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory.
Demberg T; Ettinger AC; Aladi S; McKinnon K; Kuddo T; Venzon D; Patterson LJ; Phillips TM; Robert-Guroff M
Vaccine; 2011 Aug; 29(35):6017-28. PubMed ID: 21708207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
